Novosense completes private placement of new shares. 

We are happy to announce that the new issue of shares was oversubscribed. The raised capital finances the company’s activities for 18 months. The activities include finishing the clinical studies and CE-marking of our products. For more information contact the Chairman of the board, Jonas Tilly.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top